During the past decade, Centro de Investigacion Alberto Bazzoni S.A. de C.V. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigacion Alberto Bazzoni S.A. de C.V." #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Investigacion Alberto Bazzoni S.A. de C.V." are "Heart Failure" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Lupus Erythematosus, Systemic" (1 trials). Many other conditions were trialed in "Centro de Investigacion Alberto Bazzoni S.A. de C.V." in a lesser frequency.

Most popular intervention types in "Centro de Investigacion Alberto Bazzoni S.A. de C.V." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "GDC-0853" (2 trials), "Acetaminophen/Paracetamol" (1 trials) and "Diphenhydramine hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Investigacion Alberto Bazzoni S.A. de C.V." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Investigacion Alberto Bazzoni S.A. de C.V.". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro de Investigacion Alberto Bazzoni S.A. de C.V., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Investigacion Alberto Bazzoni S.A. de C.V., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".